Cell Wall Inhibtors and Abx Resistance Flashcards

(64 cards)

1
Q

Selective Toxicity

A

Antibacterial but not toxic to the host

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cell Wall Synthesis Inhibitors

A
  • β-lactams
    • Penicillins
    • Cephalosporins
    • Carbapenems
    • Monopenems
  • Glycopeptides
    • Vancomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

30s subunit

Protein Synthesis Inhibitors

A
  • Aminoglycosides
    • Amikacin
    • Kanamycin
    • Gentamicin
  • Tetracyclines
    • Doxycycline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

50S subunit

Protein Synthesis Inhibitors

A
  • Macrolides
    • Erythromycin
    • Clarithromycin
    • Azithromycin
  • Lincosamides
    • Clindamycin
  • Chloramphenicol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

DNA Gyrase Inhibitors

A

Quinolones

e.g. Ciprofloxacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

RNA polymerase Inhibitors

A

Rifamycins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Folate Synthesis Inhibtors

A
  • Target dihydropteroate synthase
    • Sulfonamides
      • Sulfamethoxazole
  • Target dihydrofolate reductase
    • Trimethoprim
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Other Abx Types

A
  • Nitroimidazoles
    • Metronidazole
      • Anaerobes
  • Daptomycin
    • Membrane
  • Mupirocin
    • Isoleucin tRNA synthetase
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Agar Disk Diffusion Method

(Kirby-Bauer)

A

Provides qualitative results: S/I/R

  • Bacteria swabbed on agar plate
  • Antibacterial disk placed on surface
  • Incubate overnight
  • Measure diameter of zone of growth inhibition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Broth Dilution Method

(MIC)

A

Provides quantitative results in μg/ml.

  • Minimum inhibitory concentration (MIC) ⇒ Lowest concentration of abx that inhibits growth of test organism
  • Better guide to therapy
  • Look at the first well without growth
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Minimum Bactericidal Concentration

(MBC)

A

Minimum concentration of abx that kills the organism.

  • Take 0.1 ml from MIC endpoint well
  • Grow for 48 hours
  • Drug concentration that reduced starting inoculum by 99.9%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Synergy

A

Effect of drug combo is greater than sum of the individual drugs independently.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Additive

(Indifferent)

A

Sum = components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Antagonism

A

Combo < more active drug alone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antibacterial Resistance

Mechanisms

A
  1. Enzymatic inactivation of abx
  2. Modification of Abx target
  3. Altered membrane permeability
    • Dec. uptake or inc. efflux
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Enzymatic Inactivation of Abx

A
  1. Hydrolysis
    • Beta-lactamase ⇒ PCN and cephalosporins
      • Plasmid & chromosomal
  2. Modification by acetylation, adenylation, phosphorylation
    • Aminoglycosides ⇒ chloramphenicol
      • Plasmid
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PCN & Cephaloporins

Modification of Abx Targets

A

Altered penicillin-binding protein (PBP)

Chromosomal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Aminoglycosides

Modification of Abx Targets

A

Altered 30S Subunit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Macrolides

Modification of Abx Targets

A

Erythromycin, clarithromycin, etc.

methylation of 23S rRNA of 50S subunit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Quinolones

Modification of Abx Targets

A

Altered DNA gyrase

Chromosomal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Penicillins & Cephalosporins

Altered Membrane Permeability

A

Decreased outer membrane porin proteins

(OmpF)

Channels for abx entry

(Chromosomal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Imipenem, Aminoglycosides, Quinolones

Altered Membrane Permeability

A

Decreased outer membrane permeability

(Chromosomal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Tetracyclines

Altered Membrane Permeability

A

Efflux pump

(Plasmid & Chromosomal)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Macrolides

Altered Membrane Permeability

A

Efflux pump

(msrA gene)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Methicillin
* First β-lactamase stable penicillin * Now 46% of S. aureus resistant * Use oxacillin or nafcillin * Often cross-resistant to non-β-lactams ⇒ "multiple-resistant S. aureus" * Use vancomycin
26
MRSA Mechanism
* **Acquisition of mecA gene encoding PBP2a** * Transpeptidase with very low β-lactam affinity * Cross resistant to non-β-lactam abx * Expression in bacterial populations may be low ⇒ **heterogeneous resistance** * Detect w/ PCR for mecA gene or agglutination test for PBP2a * β**-lactamase overproduction** * **Modification of existing PBPs**
27
VRE Mechanism
Vancomycin binds d-Ala-d-Ala. * **High level resistance** * **Substitute D-lactate for terminal D-Ala** * Incorporation into peptidoglycan can still occur * Vancomycin cannot bind and inhibit * VanA, VanB, VanD strains * **Low level resistance** * **Substitute D-Ser for D-Ala** * VanC, VanE, VanG strains * Resistance currently limited to Enterococci * May eventually transfer to Staph
28
Abx Resistance Genetic Origins
* **Chromosomal** * Point mutations * Low frequency * **Plasmid** * Same or related species * Low freq. by transformation * High freq. by conjugation * **Phage** * Most common * Lytic phage ⇒ generalized transduction * Lysogenic phage ⇒ specialized transduction * **Transposon** * Abx resistance genes flanked by two IS
29
Gene Transfer Mechanisms
* **Transformation** * Free DNA * Ex. Strep pneumoniae ⇒ chromosomal beta-lactamase genes * **Transduction** * Lytic phages * Ex. S. aureus ⇒ acquired beta-lactamase gene * **Conjugation** * Plasmids * Machinery encoded by Tra genes * Ex. Enterobacteria & other gram neg ⇒ most common method of transferring multidrug resistance
30
Bacitracin
* ⊗ Batoprenol * Prevents transport of cell wall monomers out of the cell * Only used topically * Treat minor skin and eye infections caused by Staph and Strep
31
Glycopeptides
* **Vancomycin** and **Dalbavancin** * Time-dependent * Poor bioavailability * Spectrum * Gram pos. aerobe and anaerobes including MRSA * Does NOT kill beta-lactam susceptible Staph as fast as beta-lactams
32
Vancomycin
* **Binds a-alanyl-d-alanine ⇒ ⊗ cell wall synthesis** * Covers many gram pos. resistant to other abx * MRSA * MSSA * Strep * Some enterococci resistant ⇒ **VRE** * PO only for C. diff * IV can cause flushing ⇒ **"red man syndrome"** * Slow infusion rate and give antihistamines * Associated with **nephrotoxicity and ototoxicity** * Inc. renal damage possible with concurrent nephrotoxins
33
Penicillin Binding Proteins | (PBP)
* Enzymes located on the cytoplasmic membrane * Responsible for cell wall synthesis * Some have transpeptidase activity * Inhibited by beta-lactam abx
34
Beta-Lactams
* All contain a beta-lactam ring * Opens up and binds PBPs * Substitutions alter pharmacologic profile
35
Beta-Lactam Pharmacokinetics
* Most are **time-dependent** * **Most eliminated via renal tubular secretion** * Except nafcillin, aztreonam, and some cephalosporins * **PCN widely distrubted to most tissues except CNS** * Will cross BBB is meninges inflamed * Can be used to treat meningitis
36
Probenecide
* Used to treat gout * Inhibits tubular secretion * **Prolongs half-life of renally excreted beta-lactams**
37
Beta-lactam Hypersensitivity
* Penicillioic acid combines with host proteins to form Ag * Results in hypersensitivity reactions
38
Beta-lactam Allergies
* Patient reported drug allergies unreliable * True PCN allergies in 7-23% of pts reporting hx of allergy * PCN allergy can be confirmed through skin test * **Desensitization protocol** when PCN needed in pt with an allergy * **Cephalosporins** * Lower incidence of hypersensitivity than PCN * **5% cross-reactivity w/ PCN allergies** * **Carbapenems** * **1% cross-reactivity w/ PCN allergies** * **Aztreonam** * **No cross-reactivity w/ PCN allergies**
39
Beta-Lactams Adverse Effects
* Hypersensitivity reactions * _Ampicillin_ * Likely to cause **skin rash in pts w/ certain viral infections** like monomucleosis * _PCN @ high doses_ * **Seizures** * Disrupt gut flora ⇒ **diarrhea and superinfections like C. diff** * Esp. 3rd/4th gen. cephalosporins, fluoroquinolones, carbapenems, clindamycin
40
Penicillin Resistance Mechanisms
* **Inactivation of abx by beta-lactamase** * Chromosomal and plasmid expression * Constitutive or inducible expression * Ex. Staph to Penicillin G * **Reduced affinity of PBP for abx** * Ex. Staph to methicillin * **Decreased entry of the drug into bacteria through outer membrane porins** * Ex. Gram neg. to various beta-lactams
41
Narrow-Spectrum Penicillins
"Natural Penicillins" * Meds: * **Penicillin G** ⇒ IV * **Pencillin V** ⇒ PO * Procaine and benzathine penicillin ⇒ long acting depot * 30 min half-life ⇒ frequent doses * Most bacteria are resistant * Useful spectrum: * **Strep** * **Enterococci** * **Treponema pallidum** * Main uses: * Susceptible strep infections * Syphilis
42
Penicillinase-Resistant Penicillins
"Antistaphylococcal" * Meds: * **Nafcillin** * Hepatically eliminated * High incidence of phlebitis * **Oxacillin** * **Dicloxacillin** * Not routinely used d/t dosing issues * Spectrum: * **MSSA** * **Strep** * Uses: * **Suseptible staph infections** * Endocarditis, osteomyelitis, cellulitis * If staph resistant to one, resistant to all ⇒ MRSA * Kill staph faster than vancomycin, should be used if suseptible
43
Penicillinase-sensitive Aminopenicillins
"Extended-spectrum penicillins" * Drugs: * **Amoxicillin** ⇒ IV, PO * **Ampicillin** ⇒ PO * Spectrum: * Strep * Enterococci * Listeria * H. pylori * Some non-beta-lactamase producing GNR * Uses: * URI * UTI * PUD * Enterococcal infections * **Suseptible to beta-lactamases** * Amino group ⇒ **improved gram neg. activity** * **High incidence of diarrhea when given PO**
44
Amoxicillin
* IV or PO * Higher bioavailability than ampicillin * Uses: * Prophylaxis for endocarditis in susceptible pts * Susceptible enterococci
45
Ampicillin
* Must be used w/ aminoglycoside for enterococci * Protein synthesis inhibitor * Used for serious infections * Endocarditis
46
Beta-lactamase Inhibitor Combinations
* Aminopenicillins ⇒ intrinsic activity against GNR * Beta-lamtamase inhibitors ⇒ allow drug to exert effect * **Good for empiric therapy for hospital acquired infections** * Activity against aerobe and anaerobes * **Good for mixed infections** * Intra-abdominal infections * Diabetic ulcers * Aspiration PNA
47
Antipseudomonal Penicillins Penicillinase-sensitve
* Meds: * **Piperacillin ± tazobactam** * **Ticarcillin** * Useful spectrum ⇒ parent drug + most beta-lactamase producing bacteria * **Pseudomonas** * **Strep, MSSA, enterococci** * **Anaerobes** * b. fragilis and other gut bacteria * Better GNR coverage than parent drug along * **Active against pseudomonas and other drug-resistant GNR** * Common hospital acquired infection * Tazobactam ⇒ beta-lactamase inhibitor * Restores coverage for MSSA
48
Cephalosporins
* Classified by generation * More resistant to beta-lactamase than PCN * Most have poor activity against anaerobes
49
1st Gen Cephalosporins
* Meds: * **Cefazolin** ⇒ IV * **Cephalexin** ⇒ PO * Renal elimination * **No CNS penetration** * Useful spectrum: * **MSSA** * **Strep** * **Some GNR** * Main uses: * **Surgical prophylaxis** * **Cellulitis**
50
2nd Gen Cephalosporins
* Meds: * **Cefaclor** * **Cefuroxime** * "Cephamycins" * **Cefoxitin** * **Cefotetan** * **Better gram neg. and slightly weaker gram pos. activity compared to 1st gen** * Most numerous, least commonly used * No CNS penetration * Main uses: * **URIs** * Surgical prophylaxis ⇒ cephamycins
51
Cephamycins
**Active against many anaerobes in GI tract.** **Used for surgical prophylaxis in abdominal surgery.** * **Cefoxitin** * **Cefotetan** * N-methylthiotetrazole **(MTT) side chain** * **⊗ Vit K production** * Prolongs bleeding * **⊗ acetaldehyde dehydrogenase** * Causes flushing with ETOH ⇒ **disulfiram-like reaction**
52
3rd Gen Cephalosporins
**Broad spectrum agents** * Meds: * **Ceftriaxone** * **Cefotaxime** * **Cefpodoxime** * **Ceftazidime ± avibactam** * No gram pos. coverage * Covers pseudomonas * **Enters CNS** * Compared with 2nd gen * ↑ **Gram neg.** * **↑ Strep** * **↓ Staph** * Main uses * Meningitis * CAP/HAP * Lyme disease * Skin and soft tissue infections * UTI * Febrile neutropenia * Gonorrhea
53
Ceftriaxone
* **Dual elimination ⇒ liver and renal** * No dose adj. for renal function * Uses: * Hospital aq. meningitis and HAP * Strep. pneumonae coverage * CAP * Strep. pneumonae most common * Lymes disease * Skin/soft tissue * Not great but convient qDay dose * UTI * **Gonorrhea** * **Ceftriaxone + Azithromycin for chlamydia**
54
Cefpodoxime
**Has MMT Side Chain.** ⊗ Vit K production ⊗ acetaldehyde dehydrogenase ⇒ disulfiram-like reaction
55
Ceftazidime
* No gram + coverage * **Does cover pseudomonas** * Given with **avibactam** * Cephalosporin/beta-lactamase inhibitor combo * Combo active against many gram neg. bacteria * **Treat complicated intraadominal and urinary tract infections**
56
4th Gen Cephalosporin
**Cefepime** * **Broadest spectrum cephalosporin** * **Gram neg** * **Gram pos** * **Pseudomonas** * **Not as good against anaerobes** * More rapid penetration * Able to bind multiple PBPs * Lower affinity for several beta-lactamases * **Given IV only** * **Enters CNS** * **Good for many hospital aq. infections** * Overkill for community-aq. infections
57
Advanced-Gen Cephalosporin
**Ceftaroline** * **Only cephalosporin with MRSA coverage** * Designed to bind PBP 2a of MRSA * Think of it like Ceftriaxone + MRSA * Spectrum: * **MRSA** * **MSSA** * **Strep** * **Enteric GNR** * No pseudomonas coverage * **Modest activity against Enterococcus faecalis** * None against Enterococcus faecium * Uses: * **Skin and soft tissue infections** * **CAP**
58
Monobactams
**Aztreonam** * **Used for gram neg. infections in pts w/ beta-lactam allergies** * **Including pseudomonas** * **Safe to give to pts w/ beta-lactam allergies** * Except if they are allergic to Ceftazidime * **Enters CNS** * Penetrates tissues well * Renally elimiated
59
Carbapenems
**The most broad spectrum antibiotic.** * Meds: * **Imipenem/cilastin** * **Doripenem** * **Ertapenem** * **Meropenem** * **1% cross-reactivity w/ PCN allergies** * _All drugs have simiar spectrum except ertapenem_ * **MSSA, Strep, E. faecalis, anaerobes** * **Many GNR including Pseudomonas** * Drugs of choice for extended-spectrum beta-lactamase (ESBL) producing GNR * Including E. coli and Klebsiella pneumoniae * Main uses: * **Nosocomial infections** * **Mixed aerobic/anaerobic infections** * **Febrile neutropenia** * All given IV only * Renal elimination * **Higher incidence of seizures** * Causes nausea ⇒ rate-related
60
Ertapenem
* NOT effective against Pseudomonas and Acinetobacter * Longest half-life ⇒ used for outpatient infusion therapy for susceptible infections
61
Imipenem
* **Highest incidence of seizures** * **Avoid in pts w/ meningitis** * More likely to enter CNS * Metabolized in the kidneys to nephrotoxic product * ALWAYS given with **Cilastin** * Blocks this reaction
62
Membrane Integrity Disruptors
* Meds: * Daptomycin * Colistin, Polymixin B * Cyclic lipopeptides * Inserts into cell membrane * Bactericidal
63
Daptomycin
* Cyclic lipopeptide * **Concentration-dependent** * Poorly absorbed * Inactivated by surfactant ⇒ inactive in lungs * Excreted renally * Spectrum * **Gram pos. aerobes and anaerobes** * **Including MRSA and VRE** * Uses: * Bacteremia * Skin and soft tissue infections * Endocarditis * Adverse effects: * **Creatine kinase elevation** * **Myopathy** * **Rhabdomyolysis**
64
Polymyxins
**Colistin (Polymixin E) & Polymyxin B** * MOA: Bind cell membrane of gram neg. distrupting permeability * Poor bioavilability * Colistin is excreted renally * Polymyxin B is not * Given by inhalation, IV, or topical * _Spectrum:_ * **Gram neg. organisms** * **MDR Pseudomonas** * **Acinetobacter** * **Klebsiella** * Inactive against Serratia, Providentia * _Uses:_ * **MDR GNR infections** * **Topical infections** * **Prophylaxis of PNA in colonized CF patients** * _Adverse effects:_ * **Nephrotoxicity** ⇒ common * **Neurotoxicity** ⇒ uncommon